Literature DB >> 24966605

Pediatric fatty liver disease: role of ethnicity and genetics.

Pierluigi Marzuillo1, Emanuele Miraglia del Giudice1, Nicola Santoro1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) comprehends a wide range of conditions, encompassing from fatty liver or steatohepatitis with or without fibrosis, to cirrhosis and its complications. NAFLD has become the most common form of liver disease in childhood as its prevalence has more than doubled over the past 20 years, paralleling the increased prevalence of childhood obesity. It currently affects between 3% and 11% of the pediatric population reaching the rate of 46% among overweight and obese children and adolescents. The prevalence of hepatic steatosis varies among different ethnic groups. The ethnic group with the highest prevalence is the Hispanic one followed by the Caucasian and the African-American. This evidence suggests that there is a strong genetic background in the predisposition to fatty liver. In fact, since 2008 several common gene variants have been implicated in the pathogenesis of fatty liver disease. The most important is probably the patatin like phospholipase containing domain 3 gene (PNPLA3) discovered by the Hobbs' group in 2008. This article reviews the current knowledge regarding the role of ethnicity and genetics in pathogenesis of pediatric fatty liver.

Entities:  

Keywords:  Apolipoprotein C3 gene; Ethnicity; Farnesyl-diphosphate farnesyltransferase 1; Glucokinase regulatory protein; Insulin resistance; Non alcoholic fatty liver disease; Obesity; Patatin like phospholipase containing domain 3 gene

Mesh:

Substances:

Year:  2014        PMID: 24966605      PMCID: PMC4064080          DOI: 10.3748/wjg.v20.i23.7347

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  75 in total

1.  Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption.

Authors:  Jaimie N Davis; Kim-Anne Lê; Ryan W Walker; Susanna Vikman; Donna Spruijt-Metz; Marc J Weigensberg; Hooman Allayee; Michael I Goran
Journal:  Am J Clin Nutr       Date:  2010-10-20       Impact factor: 7.045

2.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  A feed-forward loop amplifies nutritional regulation of PNPLA3.

Authors:  Yongcheng Huang; Shaoqing He; John Zhong Li; Young-Kyo Seo; Timothy F Osborne; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.

Authors:  E D Slosberg; U J Desai; B Fanelli; I St Denny; S Connelly; M Kaleko; B R Boettcher; S L Caplan
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

5.  Effect of glucose, fructose, sucrose and starch on lipgenesis in rats.

Authors:  A M Cohen; A Teitelbaum
Journal:  Life Sci       Date:  1968-01-15       Impact factor: 5.037

6.  Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.

Authors:  Nicola Santoro; Clarence K Zhang; Hongyu Zhao; Andrew J Pakstis; Grace Kim; Romy Kursawe; Daniel J Dykas; Allen E Bale; Cosimo Giannini; Bridget Pierpont; Melissa M Shaw; Leif Groop; Sonia Caprio
Journal:  Hepatology       Date:  2011-12-18       Impact factor: 17.425

7.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

8.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

9.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

10.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more
  33 in total

Review 1.  Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children.

Authors:  Monica M Betancourt-Garcia; Armando Arguelles; Jorge Montes; Ambrosio Hernandez; Manish Singh; R Armour Forse
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

Review 2.  Pediatric Non-alcoholic Fatty Liver Disease.

Authors:  Vikas Uppal; Sana Mansoor; Katryn N Furuya
Journal:  Curr Gastroenterol Rep       Date:  2016-05

Review 3.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Hepatol       Date:  2015-06-18

Review 5.  Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics.

Authors:  Simona Riccio; Rosa Melone; Caterina Vitulano; Pierfrancesco Guida; Ivan Maddaluno; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Clin Pediatr       Date:  2022-03-23

6.  The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.

Authors:  Giuseppina R Umano; Sonia Caprio; Anna Di Sessa; Naga Chalasani; Daniel J Dykas; Bridget Pierpont; Allen E Bale; Nicola Santoro
Journal:  Am J Gastroenterol       Date:  2018-02-27       Impact factor: 10.864

Review 7.  NAFLD in children: new genes, new diagnostic modalities and new drugs.

Authors:  Valerio Nobili; Anna Alisi; Luca Valenti; Luca Miele; Ariel E Feldstein; Naim Alkhouri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-05       Impact factor: 46.802

8.  Transcriptomic profiling of a multiethnic pediatric NAFLD cohort reveals genes and pathways associated with disease.

Authors:  Kangning Yao; Elena Tarabra; Daniela Sia; Raffaella Morotti; Rima Fawaz; Pamela Valentino; Nicola Santoro; Sonia Caprio; Silvia Liu; Dean Yimlamai
Journal:  Hepatol Commun       Date:  2022-03-21

Review 9.  Non-alcoholic fatty liver disease in children: focus on nutritional interventions.

Authors:  Min Yang; Sitang Gong; Shui Qing Ye; Beth Lyman; Lanlan Geng; Peiyu Chen; Ding-You Li
Journal:  Nutrients       Date:  2014-10-28       Impact factor: 5.717

10.  Genetic diversity and natural selection footprints of the glycine amidinotransferase gene in various human populations.

Authors:  Asifullah Khan; Lei Tian; Chao Zhang; Kai Yuan; Shuhua Xu
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.